Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality

References

• Liu T, Zhang Y, Wan Q. Pseudomonas aeruginosa bacteremia among liver transplant recipients. Infect Drug Resist. 2018;11:2345–2356. doi:10.2147/IDR.S18028330532566
   PubMed Web of Science ®Google Scholar
• Micek ST, Wunderink RG, Kollef MH, et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care. 2015;19:219. doi:10.1186/s13054-015-0926-525944081
   PubMed Web of Science ®Google Scholar
• Horcajada JP, Montero M, Oliver A, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32(4).
   PubMed Web of Science ®Google Scholar
• Oliver A, Mulet X, Lopez-Causape C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21–22:41–59.
   PubMed Web of Science ®Google Scholar
• Gajdacs M. Carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa in urinary tract infections: opportunity for colistin sparing. Antibiotics (Basel). 2020;9(4).
   Web of Science ®Google Scholar
• Vidal F, Mensa J, Almela M, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med. 1996;156(18):2121–2126. doi:10.1001/archinte.1996.004401701390158862105
   PubMedGoogle Scholar
• Ammerlaan HS, Harbarth S, Buiting AG, et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis. 2013;56(6):798–805. doi:10.1093/cid/cis100623223600
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Antoniazzi F, Casari S, et al. P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol. 2012;91(8):1299–1304. doi:10.1007/s00277-012-1424-322349723
   PubMed Web of Science ®Google Scholar
• Pena C, Suarez C, Gozalo M, et al. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother. 2012;56(3):1265–1272. doi:10.1128/AAC.05991-1122155832
   PubMed Web of Science ®Google Scholar
• Pena C, Cabot G, Gomez-Zorrilla S, et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis. 2015;60(4):539–548. doi:10.1093/cid/ciu86625378459
   PubMed Web of Science ®Google Scholar
• Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–S89. doi:10.1086/49940616355321
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee CH, Hong MY. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED. Am J Emerg Med. 2012;30(6):852–860. doi:10.1016/j.ajem.2011.05.02921855263
   PubMed Web of Science ®Google Scholar
• Micek ST, Lloyd AE, Ritchie DJ, et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005;49(4):1306–1311. doi:10.1128/AAC.49.4.1306-1311.200515793102
   PubMed Web of Science ®Google Scholar
• Cheong HS, Kang CI, Wi YM, et al. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis. 2008;27(12):1219–1225. doi:10.1007/s10096-008-0568-518575908
   PubMed Web of Science ®Google Scholar
• Kim YJ, Jun YH, Kim YR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis. 2014;14:161. doi:10.1186/1471-2334-14-16124655422
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Kim HB, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745–751. doi:10.1086/37720012955633
   PubMed Web of Science ®Google Scholar
• Lee CH, Su TY, Ye JJ, et al. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. J Microbiol Immunol Infect. 2017;50(5):677–683. doi:10.1016/j.jmii.2015.06.00326188977
   PubMedGoogle Scholar
• Dantas RC, Ferreira ML, Gontijo-Filho PP, Ribas RM. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol. 2014;63(Pt 12):1679–1687.25261066
   PubMed Web of Science ®Google Scholar
• Suarez C, Pena C, Gavalda L, et al. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection. Int J Infect Dis. 2010;14(Suppl 3):e73–e78. doi:10.1016/j.ijid.2009.11.019
   PubMed Web of Science ®Google Scholar
• Joo EJ, Kang CI, Ha YE, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Microb Drug Resist. 2011;17(2):305–312. doi:10.1089/mdr.2010.017021381966
   PubMed Web of Science ®Google Scholar
• Recio R, Mancheno M, Viedma E, et al. Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence. Antimicrob Agents Chemother. 2020;64(2).
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. PA: Clinical and Laboratory Standards Institute;2018.
   Google Scholar
• Montero MM, Lopez MI, Knobel H, et al. Risk factors for mortality among patients with Pseudomonas aeruginosa bloodstream infections: what is the influence of XDR phenotype on outcomes? J Clin Med. 2020;9(2):514. doi:10.3390/jcm9020514
   PubMed Web of Science ®Google Scholar
• Pilmis B, Alby-Laurent F, Fasola ML, et al. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study. Eur J Pediatr. 2020;179(8):1247–1254. doi:10.1007/s00431-020-03598-432080759
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.21793988
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life (Basel). 2020;10(2).
   Web of Science ®Google Scholar
• Babich T, Naucler P, Valik JK, et al. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. Int J Antimicrob Agents. 2020;55(2):105847. doi:10.1016/j.ijantimicag.2019.11.00431770625
   PubMed Web of Science ®Google Scholar
• Hattemer A, Hauser A, Diaz M, et al. Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57(8):3969–3975.23733476
   PubMed Web of Science ®Google Scholar
• Shi Q, Huang C, Xiao T, Wu Z, Xiao Y. A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections. Antimicrob Resist Infect Control. 2019;8:68. doi:10.1186/s13756-019-0520-831057792
   PubMed Web of Science ®Google Scholar
• Paul M, Leibovici L. Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand? Clin Infect Dis. 2013;57(2):217–220.23580731
   PubMed Web of Science ®Google Scholar
• Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol. 2008;22(3):503–517. doi:10.1016/j.bpa.2008.05.00318831300
   PubMedGoogle Scholar
• Ueta H, Kitazawa Y, Sawanobori Y, et al. Single blood transfusion induces the production of donor-specific alloantibodies and regulatory T cells mainly in the spleen. Int Immunol. 2018;30(2):53–67. doi:10.1093/intimm/dxx07829361165
   PubMed Web of Science ®Google Scholar
• Zou Y, Song ZX, Lu Y, et al. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with beta-thalassemia major. J Huazhong Univ Sci Technol Med Sci. 2016;36(4):509–513. doi:10.1007/s11596-016-1616-5
   Google Scholar
• Deng S, Feng S, Wang W, Zhu H, Gong Y. Bacterial distribution and risk factors of nosocomial blood stream infection in neurologic patients in the Intensive Care Unit. Surg Infect (Larchmt). 2019;20(1):25–30. doi:10.1089/sur.2018.08530234461
   PubMed Web of Science ®Google Scholar
• Zhang L, Liao Q, Zhang T, Dai M, Zhao Y. Blood transfusion is an independent risk factor for postoperative serious infectious complications after pancreaticoduodenectomy. World J Surg. 2016;40(10):2507–2512. doi:10.1007/s00268-016-3553-727184137
   PubMed Web of Science ®Google Scholar
• Tam VH, Rogers CA, Chang KT, et al. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010;54(9):3717–3722. doi:10.1128/AAC.00207-1020585122
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Burian K, Terhes G. Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics (Basel). 2019;8(3).
   Web of Science ®Google Scholar
• Gajdacs M, Urban E. Epidemiological trends and resistance associated with stenotrophomonas maltophilia bacteremia: a 10-year retrospective cohort study in a tertiary-care hospital in Hungary. Diseases. 2019;7(2).
   Web of Science ®Google Scholar
• Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care. 2014;18(6):668. doi:10.1186/s13054-014-0668-925672496
   PubMed Web of Science ®Google Scholar